Clinical Trial Update: Trial LEP-F1 + GLA-SE in Healthy Adult in Areas Endemic for Leprosy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating LEP-F1 vaccine with GLA-SE adjuvant in healthy adults in leprosy-endemic areas; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy

Drugs mentioned

• GLA-SE adjuvant (GLA-SE)
• LEP-F1 vaccine (LEP-F1)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Leprosy | Phase 1 | Status: NOT_YET_RECRUITING